Novel Toll-like receptor-4 deficiency attenuates trastuzumab (Herceptin) induced cardiac injury in mice
© Yousif and Al-amran; licensee BioMed Central Ltd. 2011
Received: 23 November 2010
Accepted: 14 October 2011
Published: 14 October 2011
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|23 Nov 2010||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|28 Dec 2010||Reviewed||Reviewer Report - Manuela Bergmann|
|21 Jan 2011||Reviewed||Reviewer Report - Simon Kennedy|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|9 Mar 2011||Author responded||Author comments - Nasser Yousif|
|31 Mar 2011||Reviewed||Reviewer Report - Simon Kennedy|
|10 Apr 2011||Reviewed||Reviewer Report - Manuela Bergmann|
|Resubmission - Version 5|
|9 Mar 2011||Submitted||Manuscript version 5|
|14 Oct 2011||Editorially accepted|
|14 Oct 2011||Article published||10.1186/1471-2261-11-62|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.